- A new study looks at fake news online.
- Fake news spreads quickly on social media platforms.
- Many people like and share such posts often.
- Emotions make people react and share quickly.
- Angry and fearful posts get more attention from users.
- Researchers studied how people judge news items online.
- They looked at truth, feeling, and personal relevance.
- They tested many short posts about health news online.
- Schools can teach media literacy skills to children.
Difficult words
- fake — not real or not true information
- spread — move to many people quicklyspreads
- platform — a website or app for many usersplatforms
- emotion — a strong feeling people haveEmotions
- researcher — a person who studies a topic carefullyResearchers
- judge — decide if something is true or not
- literacy — the ability to read and understand information
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Related articles
Territory fights help Ngogo chimpanzees have more babies
Study of Ngogo chimpanzees in Uganda finds that killing neighbouring groups and expanding territory led to more births and much better infant survival in the three years after expansion.
Who decides tropical medicine research?
A new analysis finds most journal editors in tropical medicine come from wealthy countries. The study links editorial imbalance to funding gaps and calls for more diversity, local training and fairer partnerships.
Calorie restriction improves muscle insulin response in old rats
In 24-month-old rats, eating 35% less for eight weeks changed many muscle proteins and improved insulin-stimulated glucose uptake. Males and females showed different molecular responses, and two proteins may be targets for diabetes treatment.
Antibody therapy clears traces of multiple myeloma
A phase 2 trial found that an antibody drug, linvoseltamab, removed detectable disease in patients with multiple myeloma using very sensitive bone marrow tests. Researchers report acceptable safety and will expand the trial.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.